We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,790 hedge funds and large institutions have $326B invested in Johnson & Johnson in 2022 Q4 according to their latest regulatory filings, with 322 funds opening new positions, 1,605 increasing their positions, 1,494 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 322 | Existing positions closed: 82

12% more call options, than puts

Call options by funds: $3.5B | Put options by funds: $3.12B

11% more capital invested

Capital invested by funds: $295B → $326B (+$31.3B)

5% more funds holding

Funds holding: 3,6233,790 (+167)

7% more repeat investments, than reductions

Existing positions increased: 1,605 | Existing positions reduced: 1,494

0.88% more ownership

Funds ownership: 68.92%69.8% (+0.88%)

3% less funds holding in top 10

Funds holding in top 10: 730706 (-24)

Holders
3,790
Holders Change
+167
Holders Change %
+4.61%
% of All Funds
60.9%
Holding in Top 10
706
Holding in Top 10 Change
-24
Holding in Top 10 Change %
-3.29%
% of All Funds
11.35%
New
322
Increased
1,605
Reduced
1,494
Closed
82
Calls
$3.5B
Puts
$3.12B
Net Calls
+$377M
Net Calls Change
-$547M
Name Holding Trade Value Shares
Change
Change in
Stake
BWM
1426
Baystate Wealth Management
Massachusetts
$4.97M +$271K +1,568 +6%
DCM
1427
Dupont Capital Management
Delaware
$4.96M -$2.68M -15,498 -36%
GC
1428
Globeflex Capital
California
$4.96M +$2.56M +14,800 +112%
PFS
1429
Physicians Financial Services
North Carolina
$4.96M -$60.3K -349 -1%
CFMC
1430
Curbstone Financial Management Corp
New Hampshire
$4.95M -$66.3K -384 -1%
KFGK
1431
Keystone Financial Group (Kentucky)
Kentucky
$4.94M -$224K -1,298 -4%
MMHP
1432
Murphy Middleton Hinkle & Parker
Georgia
$4.93M -$32.3K -187 -0.7%
SP
1433
Symmetry Partners
Connecticut
$4.93M -$967K -5,600 -17%
WPC
1434
Wedmont Private Capital
Pennsylvania
$4.93M +$1.01M +5,842 +27%
MA
1435
McBroom & Associates
Nevada
$4.92M -$218K -1,263 -4%
MC
1436
Mayar Capital
United Kingdom
$4.92M -$5.71M -33,054 -54%
LC
1437
Lincoln Capital
Nebraska
$4.87M -$24.9K -144 -0.5%
AF
1438
Advisornet Financial
Minnesota
$4.87M -$222K -1,285 -4%
PS
1439
Pensionfund Sabic
Netherlands
$4.86M
PTC
1440
Philadelphia Trust Company
Pennsylvania
$4.86M -$185K -1,069 -4%
HP
1441
Hyperion Partners
Pennsylvania
$4.85M +$4.74M +27,480 New
MP
1442
McDonald Partners
Ohio
$4.85M +$109K +632 +2%
TNBTD
1443
Trustmark National Bank Trust Department
Mississippi
$4.85M +$542K +3,137 +13%
SACTSONJ
1444
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$4.84M
MPIM
1445
McGinn Penninger Investment Management
Virginia
$4.83M -$78K -452 -2%
SFA
1446
Semmax Financial Advisors
North Carolina
$4.82M +$5.53K +32 +0.1%
HCA
1447
Harbour Capital Advisors
Virginia
$4.82M -$46.4K -269 -1%
QPWM
1448
Quadrant Private Wealth Management
Pennsylvania
$4.79M +$4.69M +27,134 New
EF
1449
Exeter Financial
Arizona
$4.79M -$863 -5 -0%
MYIA
1450
Mount Yale Investment Advisors
Colorado
$4.79M +$155K +900 +3%

JNJ Hedge Fund Activity: Q4 2022 in Review

3,790 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2022, worth a combined $326B — up 11% from $295B a quarter earlier.

Buyers outnumbered sellers: 322 funds opened new JNJ positions and 82 closed out — a net gain of 240 holders — while 1,605 added to existing stakes and 1,494 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $781M. The largest seller was Marshall Wace, cutting an estimated $312M.

  • 3,790 institutional investors held Johnson & Johnson (JNJ) as of Q4 2022, up from 3,623 in Q3 2022.
  • Funds reported $326B of Johnson & Johnson stock for Q4 2022, up 11% quarter-over-quarter.
  • 322 funds opened new Johnson & Johnson positions in Q4 2022 and 82 closed out, a net change of +240 holders.
  • The largest Johnson & Johnson buyer in Q4 2022 was Morgan Stanley, an estimated $781M added.
  • The largest Johnson & Johnson seller in Q4 2022 was Marshall Wace, an estimated $312M sold.

Based on aggregated 13F filings for Q4 2022.